People affected by cancer in Switzerland and northern Italy have an opportunity during the ESMO Congress Lugano to talk about the latest in cancer research and share their knowledge and personal experiences, at the 6th ESMO Patient Seminar.
A promising new therapy for protecting the fertility of women with cancer and auto-immune diseases such as lupus was revealed at the 23rd annual conference of the European Society of Human Reproduction and Embryology (Tuesday, July 3 2007).
Artificially replicating the male genome could help men with very low sperm counts become fathers, a scientist told the 23rd annual conference of the European Society of Human Reproduction and Embryology (Tuesday 3 July). Professor Takumi Takeuchi, of Weill Medical College, Cornell University, New York, USA, said that mouse experiments by his team, led by Professor Gianpiero D. Palermo, had shown that offspring born as a result of such replication had shown a level of abnormalities consistent with that shown in cloned animals.
Possible new directions for the treatment of endometriosis, a painful condition associated with infertility that affects up to 15 percent of women of reproductive age, will be outlined in the presentation of two experimental studies at the 23rd annual conference of the European Society of Human Reproduction and Embryology.
Scientists in Israel have been able to obtain and freeze eggs from the ovarian tissue of girls as young as 5 years old, the 23rd annual conference of the European Society of Human Reproduction and Embryology will hear on Tuesday.
A tiny, blind, hairless subterranean rodent that lives in social colonies in the harsh, semi-arid conditions of Africa could shed light on stress-related infertility in humans, the 23rd annual meeting of the European Society of Human Reproduction and Embryology will hear.
Health Canada is aware of the growing body of evidence on the role of vitamin D in relation to health. Before Health Canada can issue a revised recommendation concerning vitamin D, a comprehensive review that looks at both benefits and safety needs to be undertaken.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for VYVANSE? (lisdexamfetamine dimesylate) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
More than 140 countries are meeting in Bangkok, Thailand, from Saturday to move forward the global tobacco control agenda during the second session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control (WHO FCTC).
Advanced Cell Technology, Inc. (OTCBB:ACTC ? News) has successfully produced a human embryonic stem cell (hESC) line without destroying an embryo at its lab in Worcester, Massachusetts.